Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme

Glioblastoma Multiforme (GBM) is the most common malignant primary brain tumor. Despite aggressive multimodality treatment it remains one of the most challenging and intractable cancers (1]. While current standard of care treatment for GBM is maximal safe surgical resection, systemic chemotherapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Christopher, Lunking, Emma S., de la Fuente, Macarena, Ayad, Nagi G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243054/
https://www.ncbi.nlm.nih.gov/pubmed/30483476
http://dx.doi.org/10.3389/fonc.2018.00521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243054/
https://www.ncbi.nlm.nih.gov/pubmed/30483476
http://dx.doi.org/10.3389/fonc.2018.00521

Ejemplares similares